BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 7348180)

  • 1. [Control of coagulation in extracorporeal circulation. Importance of the routine use of activated blood coagulation time].
    Evora PR; Brasil JC; Otaviano AG; Margarido EA; Ribeiro PJ; Reis CL; Silva JR; Secches AL
    Arq Bras Cardiol; 1981 Aug; 37(2):89-93. PubMed ID: 7348180
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood coagulation studies and extracorporeal circulation in man.
    Thurnherr N
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):634-46. PubMed ID: 5590250
    [No Abstract]   [Full Text] [Related]  

  • 3. [Routine heparinization and activated clotting time (ACT) in patients operated on under extracorporeal circulation].
    Kalawski R; Krzyś T; Leciej M
    Wiad Lek; 1982 Oct; 35(18):1119-24. PubMed ID: 7179984
    [No Abstract]   [Full Text] [Related]  

  • 4. [Value of the determination of activated coagulation time for decreasing heparin and protamine sulfate doses during operations with artificial circulation].
    Savina ME; Piatnitskaia GK; Kukaeva EA; Charnaia MA; Charnyĭ ISh
    Anesteziol Reanimatol; 1981; (5):52-6. PubMed ID: 7325386
    [No Abstract]   [Full Text] [Related]  

  • 5. [Protamine dosage for heparin neutralization in open-heart surgery (author's transl)].
    Shiao K
    Fukuoka Igaku Zasshi; 1974 Nov; 65(11):878-88. PubMed ID: 4477114
    [No Abstract]   [Full Text] [Related]  

  • 6. Heparin rebound. Studies in patients and volunteers.
    Ellison N; Beatty CP; Blake DR; Wurzel HA; MacVaugh H
    J Thorac Cardiovasc Surg; 1974 May; 67(5):723-9. PubMed ID: 4823307
    [No Abstract]   [Full Text] [Related]  

  • 7. [Heparinization control by activated coagulation time in cardiac surgery with extracorporeal circulation].
    Daudt CA; Pereira SN; Moraes LB; Costa PS; Deboni LM; Figueiredo MS
    Arq Bras Cardiol; 1989 Mar; 52(3):137-9. PubMed ID: 2597000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual responses to heparinization for extracorporeal circulation.
    Friesen RH; Clement AJ
    J Thorac Cardiovasc Surg; 1976 Dec; 72(6):875-9. PubMed ID: 994537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of blood coagulation in open heart surgery. II. Use of individualized dosages of heparin and protamine controlled by activated coagulation times.
    Dercksen SJ; Linssen GH
    Acta Anaesthesiol Belg; 1980; 31(2):121-8. PubMed ID: 7468138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blood coagulation in extracorporeal circulation].
    Encke A
    Thoraxchir Vask Chir; 1969 Oct; 17(5):414-21. PubMed ID: 5312407
    [No Abstract]   [Full Text] [Related]  

  • 11. [Activated coagulation time and the concentration of heparin in assessing the level of blood heparinization during operations using artificial blood circulation].
    Khodas MIa; Piatnitskaia GKh; Savina ME; Smirnova LA
    Anesteziol Reanimatol; 1989; (2):11-5. PubMed ID: 2742179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Present state of heparin therapy].
    Blatrix C; Soulier JP; Vacheron A; Cornu P
    Presse Med (1893); 1969 Mar; 77(15):553-6. PubMed ID: 5796027
    [No Abstract]   [Full Text] [Related]  

  • 13. Control of heparin therapy in open-heart surgery.
    Jaberi M; Bell WR; Benson DW
    J Thorac Cardiovasc Surg; 1974 Jan; 67(1):133-41. PubMed ID: 4808908
    [No Abstract]   [Full Text] [Related]  

  • 14. ["Heparin rebound" and fibrinolytic activity in extracorporeal circulation (author's transl)].
    Sanz MA; Aznar JA; Tascón A; Martínez J; Marty ML
    Sangre (Barc); 1977; 22(3):346-50. PubMed ID: 867212
    [No Abstract]   [Full Text] [Related]  

  • 15. Monitoring of blood coagulation in open heart surgery. I. Effects of conventional dosages of heparin and protamine.
    Dercksen SJ; Linssen GH
    Acta Anaesthesiol Belg; 1980; 31(2):113-9. PubMed ID: 7468137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of activated coagulation time for controlling the heparinization level during operations with artificial circulation].
    Dement'eva II; Savina ME; Piatnitskaia GKh
    Anesteziol Reanimatol; 1980 Aug; (4):29-32. PubMed ID: 7416544
    [No Abstract]   [Full Text] [Related]  

  • 17. Heparin dosage in extracorporeal circulation and its neutralization.
    Nyman D; Thurnherr N; Duckert F
    Thromb Diath Haemorrh; 1975 Feb; 33(1):102-4. PubMed ID: 1118825
    [No Abstract]   [Full Text] [Related]  

  • 18. Improved survival rates in dogs after extracorporeal circulation by improved control of heparin levels.
    Akkerman JW; Runne WC; Sixma JJ; Zimmerman AN
    J Thorac Cardiovasc Surg; 1974 Jul; 68(1):59-65. PubMed ID: 4834066
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blood coagulation and fibrinolysis in venous blood after prophylactic use of antifibrinolytic agents in heart surgery with the use of xtracorporeal circulation].
    Deutschinoff A; Dimitrov D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):166-73. PubMed ID: 4174654
    [No Abstract]   [Full Text] [Related]  

  • 20. [Control of heparin and protamine administration (author's transl)].
    Yuge I; Fujii N; Yamada M; Anzai N
    Kyobu Geka; 1979 May; 32(5):337-40. PubMed ID: 459164
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.